Chronic oral methylene blue treatment in a rat model of focal cerebral ischemia/reperfusion (2017)

Peer-Reviewed Study · Huang L, Lu J, Cerqueira B, Liu Y, Jiang Z, Duong TQ · November 8, 2017

Huang L et al., 2017-11-08: Randomized, double-blinded, vehicle-controlled rat MCAO study: 21 days of oral MB (4 mg/kg in gel food) improved behaviour, lesion volume and white-matter damage up to 60 days.

chronic oral MB treatment, compared to vehicle, i) improves functional behavioral outcomes starting on day 7 and up to 60 days

Huang L et al., 2017-11-08: Randomized, double-blinded, vehicle-controlled rat MCAO study: 21 days of oral MB (4 mg/kg in gel food) improved behaviour, lesion volume and white-matter damage up to 60 days. ANIMAL ONLY (male Sprague-Dawley rats, 12 randomized after MRI screening, 6 per group, 1 rat/group died). Stony Brook Medicine. Dose 4 mg/kg/day oral in gel food, day 1-21 post-stroke. Comparator: blue-dye gel food vehicle. Double-blinded, randomized. Funding: NIH/NINDS R01-NS45879 (full text); authors declare no conflict of interest. Product: USP grade MB, American Regent Inc. No human data. Study type: animal.